fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » UTI Healthcare Fund Vs SBI Healthcare Opportunities Fund

UTI Healthcare Fund Vs SBI Healthcare Opportunities Fund

Updated on November 17, 2024 , 909 views

UTI Healthcare Fund and SBI Healthcare Opportunities Fundis a comparative article that eases the option or process of choosing one fund of the same category for the investors. Both the funds belong to the same category of Mutual Funds- healthcare sector equity. sector funds are a type of mutual fund that invests in securities of specific sectors of the Economy, such as telecom, banking, FMCG, Information Technology (IT), healthcare pharmaceutical and infrastructure. Sector funds carry a higher Volatility than any other Equity Funds. As, high-risk comes with high-reward, sector funds seem to comply with it. So, let us understand the differences between UTI Healthcare Fund and SBI Healthcare Opportunities Fund by comparing various parameters such as AUM, NAV, performance, and so on.

UTI Healthcare Fund (Erstwhile UTI Pharma & Healthcare Fund)

UTI Healthcare Fund, earlier known as UTI Pharma & Healthcare Fund, was launched in the year 1999. The aim of the fund is to seek Capital appreciation through investments in equities and related instruments of the Pharma & Healthcare sectors. Being a sector-specific fund, UTI Healthcare Fund comes under high-risk investment, thus, investors who can bear risk should only prefer Investing in this fund.

Some of the top holdings of the fund (as on 31st Jul'18) are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Pfizer Ltd, Sanofi India Ltd, Ipca Laboratories Ltd, etc.

SBI Healthcare Opportunities Fund (Erstwhile SBI Pharma Fund)

SBI Healthcare Opportunities Fund, earlier known as SBI Pharma Fund, was launched in the year 2004. The fund aims to provide maximum growth opportunity by investing in equity investments in stocks of growth-oriented sectors of the economy. This fund carries high-risk, so investors with the same risk appetite should only prefer investing in this fund.

Some of the top holdings of the fund, as on 31st July 2018, are Cblo, Sun Pharmaceuticals Industries Ltd, Strides Pharma Science Ltd, Aurobindo Pharma Ltd, Torrent Pharmaceuticals Ltd, etc.

UTI Healthcare Fund Vs SBI Healthcare Opportunities Fund

Basics Section

Being the first section, it compares parameters such as current NAV, Fincash Rating, AUM, expense ratio, scheme category and many more. With respect to scheme category, both the schemes are a part of the same category, Sector Equity.

Based on Fincash Rating, it can be said that, UTI Healthcare Fund is rated as 1-Star scheme and SBI Healthcare Opportunities Fund is rated as 2-Star scheme.

The comparison of the basics section is as follows.

Parameters
BasicsNAV
Net Assets (Cr)
Launch Date
Rating
Category
Sub Cat.
Category Rank
Risk
Expense Ratio
Sharpe Ratio
Information Ratio
Alpha Ratio
Benchmark
Exit Load
UTI Healthcare Fund
Growth
Fund Details
₹278.237 ↑ 1.80   (0.65 %)
₹1,187 on 31 Oct 24
28 Jun 99
Equity
Sectoral
40
High
2.38
2.81
-0.28
-2.15
Not Available
0-1 Years (1%),1 Years and above(NIL)
SBI Healthcare Opportunities Fund
Growth
Fund Details
₹408.697 ↓ -4.58   (-1.11 %)
₹3,416 on 31 Oct 24
31 Dec 04
Equity
Sectoral
34
High
2.09
3.45
0.68
6.3
Not Available
0-15 Days (0.5%),15 Days and above(NIL)

Performance Section

Being the second section, it analyses the differences in the Compounded Annual Growth Rate or CAGR returns of both the schemes. These CAGR returns are compared at different time intervals such as 1 Month Return, 6 Month Return, 5 Year Return, and Return since Inception. The comparison of CAGR returns reveals that in some instance UTI Healthcare Fund has performed better, while in some SBI Healthcare Opportunities Fund has performed well. The table given below summarizes the comparison of the performance section.

Parameters
Performance1 Month
3 Month
6 Month
1 Year
3 Year
5 Year
Since launch
UTI Healthcare Fund
Growth
Fund Details
-3.4%
3.4%
23.6%
44.5%
19.7%
27.5%
15.3%
SBI Healthcare Opportunities Fund
Growth
Fund Details
-2.9%
4.4%
17.6%
42.4%
22.6%
28.5%
15.8%

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Yearly Performance Section

The comparison of absolute returns generated by both the schemes for a particular year is done in the yearly performance section. The analysis of absolute returns shows that in most years SBI Healthcare Opportunities Fund has performed well. The summary comparison of the yearly performance section is tabulated as follows.

Parameters
Yearly Performance2023
2022
2021
2020
2019
UTI Healthcare Fund
Growth
Fund Details
38.2%
-12.3%
19.1%
67.4%
1.2%
SBI Healthcare Opportunities Fund
Growth
Fund Details
38.2%
-6%
20.1%
65.8%
-0.5%

Other Details Section

The minimum SIP Investment and minimum lumpsum investment are some of the parameters that form part of the other details section. The minimum lumpsum and SIP investment for both the schemes is the same, i.e., INR 5000 and INR 500, respectively. The table given below summarizes the comparison of other details section.

SBI Healthcare Opportunities Fund is currently managed by Tanmaya Desai.

UTI Healthcare Fund is currently managed by V Srivatsa.

Parameters
Other DetailsMin SIP Investment
Min Investment
Fund Manager
UTI Healthcare Fund
Growth
Fund Details
₹500
₹5,000
Kamal Gada - 2.5 Yr.
SBI Healthcare Opportunities Fund
Growth
Fund Details
₹500
₹5,000
Tanmaya Desai - 13.43 Yr.

Growth of 10k Investments over the years

Growth of 10,000 investment over the years.
UTI Healthcare Fund
Growth
Fund Details
DateValue
31 Oct 19₹10,000
31 Oct 20₹15,449
31 Oct 21₹19,772
31 Oct 22₹18,618
31 Oct 23₹21,719
31 Oct 24₹34,592
Growth of 10,000 investment over the years.
SBI Healthcare Opportunities Fund
Growth
Fund Details
DateValue
31 Oct 19₹10,000
31 Oct 20₹15,024
31 Oct 21₹19,094
31 Oct 22₹19,411
31 Oct 23₹23,158
31 Oct 24₹36,478

Detailed Portfolio Comparison

Asset Allocation
UTI Healthcare Fund
Growth
Fund Details
Asset ClassValue
Cash1.42%
Equity98.47%
Debt0.11%
Equity Sector Allocation
SectorValue
Health Care95.93%
Basic Materials1.5%
Financial Services1.04%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA
11%₹134 Cr725,000
↓ -10,274
Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 500087
6%₹70 Cr450,660
↑ 660
Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 532331
5%₹64 Cr208,365
↑ 8,365
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY
5%₹55 Cr435,500
Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND
4%₹44 Cr266,306
↑ 96,263
Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 532296
4%₹42 Cr250,331
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP
4%₹42 Cr60,000
↓ -4,796
Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 532843
3%₹40 Cr634,445
Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL
3%₹39 Cr74,000
Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | ERIS
3%₹36 Cr275,361
Asset Allocation
SBI Healthcare Opportunities Fund
Growth
Fund Details
Asset ClassValue
Cash3.26%
Equity96.74%
Equity Sector Allocation
SectorValue
Health Care90.2%
Basic Materials6.54%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA
13%₹444 Cr2,400,000
↑ 200,000
Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH
6%₹214 Cr2,100,000
↑ 100,000
Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB
6%₹212 Cr360,000
Poly Medicure Ltd (Healthcare)
Equity, Since 31 Aug 24 | POLYMED
5%₹184 Cr640,000
Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 500257
5%₹175 Cr800,000
Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LZAGY
5%₹156 Cr300,000
Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 500087
5%₹155 Cr1,000,000
Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 543308
4%₹136 Cr2,500,000
Jupiter Life Line Hospitals Ltd (Healthcare)
Equity, Since 31 Aug 23 | JLHL
4%₹121 Cr900,000
Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND
4%₹120 Cr450,000

Therefore, in a nutshell, it can be said that both the schemes differ on account of numerous parameters. As a consequence, individuals should be very careful while choosing any of the schemes for investment. They should understand the modalities of the scheme completely and check whether the scheme matches their investment parameters or not. This will help individuals to attain their objectives on time and in a hassle-free manner.

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data. Please verify with scheme information document before making any investment.
How helpful was this page ?
Rated 5, based on 2 reviews.
POST A COMMENT